ACIP vote, more FDA turnover; Introducing Endpoints Signal; ARCH, Parker Institute building next cancer bet; and more

Welcome to Endpoints Weekly! We’re glad to be back after the holiday weekend. We have a lot to recap this week, starting with more change at the FDA. The agency tapped Tracy Beth Høeg as ...